ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels (Hep C Chronic Fatigue)

ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels
Primezone Media Network - Incorporated ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels of concept study with HCV-796, an orally dosed hepatitis C (HCV) viral polymerase

Hepatitis C Leadership Summit Engages HCV Stakeholders to Elevate the Response to the HCV Epidemic
Business Wire via Yahoo! - BOSTON--(BUSINESS WIRE)--Nov. been infected by the hepatitis C virus (HCV). Because no significant new federal resources to fight the HCV epidemic are planned for the near